AZ fills top R&D spot with Genentech's Bohen; Regulators OK Pfizer's Hospira deal;

> Genentech's Sean Bohen will take up the post as AstraZeneca's ($AZN) R&D chief. More

> Regulators have approved Pfizer's ($PFE) Hospira ($HSP) buyout deal, pending the divestiture of some sterile injectable drugs. Report

> Bayer HealthCare has launched a digital healthcare accelerator in Berlin. Report

> South Korean pharmaceutical companies are beefing up their presence in the global healthcare industry through global partnerships. More

> Merck KGaA will close down Bangalore GeNei, a company it acquired in 2009 to boost its capabilities in design, development and production of biological research products. More

And Finally... Google's ($GOOG) Life Sciences division is developing a wearable blood glucose monitor that could revolutionize diabetic care and treatment. Report